← Back to Patent Explorer
US4141983A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for inhibiting ADP-induced platelet aggregation using phenylthioalkylamines

Assignee: Dow Chemical Co
•
Filing: 1977-09-14
•
Granted: 1979-02-27
•
Expires: 1997-09-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for inhibiting blood platelet aggregation in a mammal by administering internally to the mammal an effective amount of a phenylthio(sulfinyl or sulfonyl)alkylamine compound or a pharmaceutically-acceptable salt thereof.

Inventors

  • 👤 Joseph E. Dunbar
  • 👤 Louis E. Begin
  • 👤 Robert J. Broesma
  • 👤 George D. Dickerson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 18:20
CPC Classifications
C; C07; C07D; C07D295/00; C07D295/04; C07D295/08; C07D295/084; C07D295/088

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 128 words
A method for inhibiting ADP-induced platelet aggregation and treating thrombosis in a mammal in need thereof comprising administering internally to said mammal a platelet aggregation inhibiting amount of a compound corresponding to the formula: ##STR3## and the pharmaceutically-acceptable salts thereof wherein: R 1 is piperidino; R 2 is lower alkyl or hydrogen; R 3 is, lower alkyl, halo, hydroxy, amino, acetamino, acetoxy, lower alkoxy, or carboxy; r is an integer of from 0 to 5; x is an integer of from 0 to 2; y is an integer of from 0 to 4 with the proviso that when R 2 is lower alkyl, y is 1; and z is an integer of from 0 to 3 with the proviso that when R 2 is hydrogen z is 0.
Claim 2
Independent Claim 128 words
A method for inhibiting ADP-induced platelet aggregation and treating thrombosis in a mammal in need thereof comprising administering internally to said mammal a platelet aggregation inhibiting amount of a compound corresponding to the formula: ##STR3## and the pharmaceutically-acceptable salts thereof wherein: R 1 is piperidino; R 2 is lower alkyl or hydrogen; R 3 is, lower alkyl, halo, hydroxy, amino, acetamino, acetoxy, lower alkoxy, or carboxy; r is an integer of from 0 to 5; x is an integer of from 0 to 2; y is an integer of from 0 to 4 with the proviso that when R 2 is lower alkyl, y is 1; and z is an integer of from 0 to 3 with the proviso that when R 2 is hydrogen z is 0.
Claim 3
Dependent Claim 18 words
The method of claim 1 wherein R 3 of the compound is lower alkyl, lower alkoxy, and hydroxy.
Claim 4
Dependent Claim 9 words
The method of claim 1 wherein x is 2.
Claim 5
Dependent Claim 17 words
The method of claim 1 wherein the compound is 2-(1-piperidinyl)ethyl phenyl sulfide and the pharmaceutically-acceptable salts thereof.

References Cited (Backward Citations)

GB1371650A Cited
US3988475A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-02-26 1982-08-28 1983-02-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-02-26 1986-08-28 1987-02-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-02-26 1990-08-28 1991-02-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag